The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Hit discovery and hit-to-lead approaches
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,041
A ‘Rule of Three’ for fragment-based lead discovery?
Congreve, M., Carr, R., Murray, C., & Jhoti, H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02831-9 · Cited by 1,354
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening
McGovern, S. L., Caselli, E., Grigorieff, N., & Shoichet, B. K. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010533y · Cited by 1,042
Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery
Hann, M. M., Leach, A. R., & Harper, G. (2001) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000403i · Cited by 877
Gasparini, F., Lingenhöhl, K., Stoehr, N., Flor, P. J., Heinrich, M., Vranesic, I., Biollaz, M., Allgeier, H., Heckendorn, R., Urwyler, S., et al. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00082-9 · Cited by 725
Burger, A., & Wolff, M. E. (1980) · Wiley eBooks · Cited by 708
Erlanson, D. A., McDowell, R. S., & O'Brien, T. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040031v · Cited by 642
A Specific Mechanism of Nonspecific Inhibition
McGovern, S. L., Helfand, B. T., Feng, B., & Shoichet, B. K. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030266r · Cited by 598
Pursuing the leadlikeness concept in pharmaceutical research
Hann, M. M., & Oprea, T. I. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.04.003 · Cited by 515
Site-directed ligand discovery
Erlanson, D. A., Braisted, A. C., Raphael, D. R., Randal, M., Stroud, R. M., Gordon, E. M., & Wells, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9367 · Cited by 466
Fragment-Based Lead Discovery Using X-ray Crystallography
Hartshorn, M. J., Murray, C. W., Cleasby, A., Frederickson, M., Tickle, I. J., & Jhoti, H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0495778 · Cited by 422
Cosford, N. D. P., Tehrani, L., Roppe, J., Schweiger, E., Smith, N. D., Anderson, J., Bristow, L., Brodkin, J., Jiang, X., McDonald, I., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm025570j · Cited by 396
Boehm, H.-J., Boehringer, M., Bur, D., Gmuender, H., Huber, W., Klaus, W., Kostrewa, D., Kuehne, H., Luebbers, T., Meunier-Keller, N., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000017s · Cited by 375
Liu, G., Huth, J. R., Olejniczak, E. T., Mendoza, R. R., DeVries, P. J., Leitza, S. T., Reilly, E. B., Okasinski, G. F., Fesik, S. W., & von Geldern, T. W. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000503f · Cited by 359
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate
Regan, J., Breitfelder, S., Cirillo, P., Gilmore, T., Graham, A. G., Hickey, E., Klaus, B., Madwed, J., Moriak, M., Moss, N., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020057r · Cited by 348
Fragment-based lead discovery: leads by design
Carr, R. A. E., Congreve, M., Murray, C. W., & Rees, D. C. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03511-7 · Cited by 343
Discovering novel ligands for macromolecules using X-ray crystallographic screening
Nienaber, V. L., Richardson, P. L., Klighofer, V., Bouska, J. J., Giranda, V. L., & Greer, J. (2000) · Nature Biotechnology · doi:10.1038/80319 · Cited by 322
Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR
Hajduk, P. J., Sheppard, G., Nettesheim, D. G., Olejniczak, E. T., Shuker, S. B., Meadows, R. P., Steinman, D. H., Carrera, G. M., Marcotte, P. A., Severin, J., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9702778 · Cited by 317
Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-x L from NMR and Parallel Synthesis
Petros, A. M., Dinges, J., Augeri, D. J., Baumeister, S. A., Betebenner, D. A., Bures, M. G., Elmore, S. W., Hajduk, P. J., Joseph, M. K., Landis, S. K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0507532 · Cited by 292
The SHAPES strategy: an NMR-based approach for lead generation in drug discovery
Fejzo, J., Lepre, C. A., Peng, J. W., Bemis, G. W., Ajay, Murcko, M. A., & Moore, J. M. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(00)80022-8 · Cited by 271
Stachel, S. J., Coburn, C. A., Steele, T. G., Jones, K. G., Loutzenhiser, E. F., Gregro, A. R., Rajapakse, H. A., Lai, M.-T., Crouthamel, M.-C., Xu, M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049379g · Cited by 262
Drugs, leads, and drug-likeness: an analysis of some recently launched drugs
Proudfoot, J. R. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00244-5 · Cited by 252
Szczepankiewicz, B. G., Liu, G., Hajduk, P. J., Abad-Zapatero, C., Pei, Z., Xin, Z., Lubben, T. H., Trevillyan, J. M., Stashko, M. A., Ballaron, S. J., et al. (2003) · Journal of the American Chemical Society · doi:10.1021/ja0296733 · Cited by 231
Huth, J. R., Mendoza, R., Olejniczak, E. T., Johnson, R. W., Cothron, D. A., Liu, Y., Lerner, C. G., Chen, J., & Hajduk, P. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0455547 · Cited by 228
Card, G. L., Blasdel, L., England, B. P., Zhang, C., Suzuki, Y., Gillette, S., Fong, D., Ibrahim, P. N., Artis, D. R., Bollag, G., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1059 · Cited by 208
In situ assembly of enzyme inhibitors using extended tethering
Erlanson, D. A., Lam, J. W., Wiesmann, C., Luong, T. N., Simmons, R. L., DeLano, W. L., Choong, I. C., Burdett, M. T., Flanagan, W. M., Lee, D., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt786 · Cited by 203
Advances in membrane receptor screening and analysis
Cooper, M. A. (2004) · Journal of Molecular Recognition · doi:10.1002/jmr.675 · Cited by 198
Maly, D. J., Choong, I. C., & Ellman, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.6.2419 · Cited by 189
Identification of Novel p38α MAP Kinase Inhibitors Using Fragment-Based Lead Generation
Gill, A. L., Frederickson, M., Cleasby, A., Woodhead, S. J., Carr, M. G., Woodhead, A. J., Walker, M. T., Congreve, M. S., Devine, L. A., Tisi, D., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049575n · Cited by 186
NMR-Based Discovery of Lead Inhibitors That Block DNA Binding of the Human Papillomavirus E2 Protein
Hajduk, P. J., Dinges, J., Miknis, G. F., Merlock, M., Middleton, T., Kempf, D. J., Egan, D. A., Walter, K. A., Robins, T. S., Shuker, S. B., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9703404 · Cited by 168
SAR by MS: A Ligand Based Technique for Drug Lead Discovery Against Structured RNA Targets
Swayze, E. E., Jefferson, E. A., Sannes, K. A., Blyn, L. B., Risen, L. M., Arakawa, S., Osgood, S. A., Hofstadler, S. A., & Griffey, R. H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0255466 · Cited by 145
Target-induced formation of neuraminidase inhibitors from in vitro virtual combinatorial libraries
Hochgürtel, M., Kroth, H., Piecha, D., Hofmann, M. W., Nicolau, C. S., Krause, S., Schaaf, O., Sonnenmoser, G., & Eliseev, A. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052703799 · Cited by 139
Annis, D. A., Nazef, N., Chuang, C., Scott, M. P., & Nash, H. M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja048365x · Cited by 130
Gaillard, P., Jeanclaude-Etter, I., Ardissone, V., Arkinstall, S., Cambet, Y., Camps, M., Chabert, C., Church, D. J., Cirillo, R., Gretener, D., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0310986 · Cited by 129
Park, Y.-W., Cummings, R. T., Wu, L., Zheng, S. G., Cameron, P. M., Woods, A., Zaller, D. M., Marcy, A. I., & Hermes, J. D. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4029 · Cited by 126
Human liver glycogen phosphorylase inhibitors bind at a new allosteric site
Rath, V. L., Ammirati, M. J., Danley, D. E., Ekstrom, J. L., Gibbs, E. M., Hynes, T. R., Mathiowetz, A. M., McPherson, R. K., Olson, T. V., Treadway, J. L., et al. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00004-1 · Cited by 126
Hit-to-Lead studies: The discovery of potent adamantane amide P2X7 receptor antagonists
Baxter, A., Bent, J., Bowers, K. C., Braddock, M., Brough, S., Fagura, M., Lawson, M., McInally, T., Mortimore, M., Robertson, M. J., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.034 · Cited by 124
Novel Inhibitors of Erm Methyltransferases from NMR and Parallel Synthesis
Hajduk, P. J., Dinges, J., Schkeryantz, J. M., Janowick, D. A., Kaminski, M., Tufano, M. D., Augeri, D. J., Petros, A. M., Nienaber, V. L., Zhong, P., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990293a · Cited by 119
Coburn, C. A., Stachel, S. J., Li, Y., Rush, D. M., Steele, T. G., Chen-Dodson, E., Holloway, M. K., Xu, M., Huang, Q., Lai, M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049388p · Cited by 117
Self-citationVirtual screening in lead discovery and optimization.
Jain, A. N. (2004) · PubMed · Cited by 116
Wood, W. J. L., Patterson, A. W., Tsuruoka, H., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0547230 · Cited by 114
Liu, G., Xin, Z., Liang, H., Abad‐Zapatero, C., Hajduk, P. J., Janowick, D. A., Szczepankiewicz, B. G., Pei, Z., Hutchins, C. W., Ballaron, S. J., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034088d · Cited by 109
Discovery and Characterization of a Substrate Selective p38α Inhibitor
Davidson, W. C., Frego, L., Peet, G. W., Kroe‐Barrett, R., Labadia, M. E., Lukas, S., Snow, R. J., Jakes, S., Grygon, C. A., Pargellis, C., et al. (2004) · Biochemistry · doi:10.1021/bi0495073 · Cited by 107
Fragonomics: fragment-based drug discovery
Zartler, E. R., & Shapiro, M. J. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.05.002 · Cited by 104
Vos, T. J., Caracoti, A., Che, J. L., Dai, M., Farrer, C. A., Forsyth, N. E., Drabic, S. V., Horlick, R. A., Lamppu, D., Yowe, D. L., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm034244g · Cited by 103
Annis, D. A., Athanasopoulos, J., Curran, P. J., Felsch, J. S., Kalghatgi, K., Lee, W. H., Nash, H. M., Orminati, J.-P. A., Rosner, K. E., Shipps, G. W., et al. (2004) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2003.11.022 · Cited by 100
Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors
Baxter, A., Brough, S., Cooper, A. E., Floettmann, E., Foster, S., Harding, C. J., Kettle, J. G., McInally, T., Martin, C., Mobbs, M., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.03.058 · Cited by 89
Using an Enzyme's Active Site To Template Inhibitors
Nguyen, R., & Huc, I. (2001) · Angewandte Chemie International Edition · Cited by 79
(Research Papers) Design of a Compound Screening Collection for use in High Throughput Screening
Harper, G., Pickett, S. T. A., & Green, D. V. S. (2004) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620704772884832 · Cited by 77
Lead compounds discovered from libraries: Part 2
Gołȩbiowski, A., Klopfenstein, S. R., & Portlock, D. E. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00059-0 · Cited by 74
Popa-Burke, I. G., Issakova, O., Arroway, J. D., Bernasconi, P., Chen, M., Coudurier, L., Galasinski, S., Jadhav, A., Janzen, W., Lagasca, D., et al. (2004) · Analytical Chemistry · doi:10.1021/ac0491859 · Cited by 73
Second-Site NMR Screening and Linker Design
Jahnke, W., Flörsheimer, A., Blommers, M. J. J., PARIS, C. G., Heim, J., Nalin, C. M., & Perez, L. B. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033392778 · Cited by 66
SpeedScreen: The “Missing Link” between Genomics and Lead Discovery
Zehender, H., Goff, F. L., Lehmann, N., Filipuzzi, I., & Mayr, L. M. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104267605 · Cited by 60
Baxter, A., Bennion, C., Bent, J., Boden, K., Brough, S., Cooper, A. E., Kinchin, E. C., Kindon, N. D., McInally, T., Mortimore, M., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00561-4 · Cited by 46
Oxamides as novel NR2B selective NMDA receptor antagonists
BARTA‐SZALAI, G., Borza, I., Bozó, É., Kiss, C., Ágai, B., Proszenyák, Á., Keserű, G. M., Gere, A., Kolok, S., Galgóczy, K., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.05.053 · Cited by 45
Self-citationAnnis, D. A., Athanasopoulos, J., CURRAN, P., Felsch, J. S., Kalghatgi, K., LEE, W., Nash, H. M., Orminati, J.-P. A., Rosner, K. E., & SHIPPSJR, G. (2004) · International Journal of Mass Spectrometry · doi:10.1016/s1387-3806(04)00335-5 · Cited by 43
Discovery of novel low molecular weight inhibitors of IMPDH via virtual needle screening
Pickett, S. D., Sherborne, B. S., Wilkinson, T. C. I., Bennett, J. M., Borkakoti, N., Broadhurst, M. J., Hurst, D. N., Kilford, I. R., McKinnell, M., & Jones, P. S. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00237-3 · Cited by 37
Identification of “Latent Hits” in Compound Screening Collections
Mestres, J., & Veeneman, G. H. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm034078c · Cited by 34
A Competitive Fluorescence Assay to Measure the Reactivity of Compounds
Epps, D. E. V., & Taylor, B. M. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5173 · Cited by 28
Cited by
Opportunities and obstacles for deep learning in biology and medicine
Ching, T., Himmelstein, D. S., Beaulieu-Jones, B. K., Kalinin, A. A., Do, B. T., Way, G. P., Ferrero, E., Agapow, P.-M., Zietz, M., Hoffman, M. M., et al. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0387 · Cited by 2,310
A Structure-Based Drug Discovery Paradigm
Batool, M., Ahmad, B., & Choi, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112783 · Cited by 744
The influence of lead discovery strategies on the properties of drug candidates
Keserü, G. M., & Makara, G. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2796 · Cited by 628
Self-citationRecent Developments in Fragment-Based Drug Discovery
Congreve, M., Chessari, G., Tisi, D., & Woodhead, A. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8000373 · Cited by 611
Spray drying formulation of amorphous solid dispersions
Singh, A., & Van den Mooter, G. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.010 · Cited by 526
Metadata
- Authors
- Keserű, G. M., & Makara, G. M.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2006-08
- Volume
- 11
- Issue
- 15-16
- Pages
- 741-748
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2156121510
- Cited by
- 256
- References
- 62
- FWCI
- 18.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.